CDNA vs CL · rev $333.8M vs P/E 34, rev $20.38B
CareDx Inc (CDNA) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CDNA currently screens at market cap $1.18B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the CDNA and CL stock pages for the full models.
Not investment advice.